Clinical Trial

A Study of MZE782 in Adults With PKU

Name: A Study of MZE782 in Adults With PKU — clinical trial record (NCT07694440)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CIPheR

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to evaluate the safety, tolerability, and efficacy of MZE782 in adults with Phenylketonuria (PKU).

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-07-02.

Trial Details

NCT Number	NCT07694440
Lead Sponsor	Maze Therapeutics
Conditions	Phenylketonuria (PKU)
Enrollment	38 participants
Start Date	2026-06-23
Primary Completion	2027-12 (estimated)
Study Completion	2028-02 (estimated)
Updated on ClinicalTrials.gov	2026-07-14